Literature DB >> 17414134

Reversal of liver cirrhosis: a desirable clinical outcome and its pathogenic background.

Flavia Bortolotti1, Maria Guido.   

Abstract

Cirrhosis is the final stage of chronic liver damage of various etiologies. It used to be considered an irreversible lesion, but enormous advances in our understanding of hepatic cellular and molecular biology in the past 2 decades have challenged this view. There is now substantial evidence that cirrhosis can be a reversible process. This concept is supported by an increasing number of clinical reports showing the disappearance of cirrhotic lesions from liver biopsies taken from patients cured of their liver disease. The reversal of cirrhosis usually occurs in patients with short-lived liver disease, after the successful treatment of the underlying liver damage. Recently, however, we observed the spontaneous reversal of cirrhosis after the loss of hepatitis B viremia in 2 men, 21 and 28 years old, who had developed cirrhosis as young children. Several questions and controversial issues concerning the definition of advanced cirrhosis, the limitations of liver biopsy (eg, sampling, interpretation error), and the applicability of noninvasive methods to the assessment of fibrosis, are being addressed. Future prospects include the possibility of antifibrotic therapy to prevent fibrosis or favor its degradation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17414134     DOI: 10.1097/MPG.0b013e318032069a

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  8 in total

Review 1.  Natural regression of fibrosis in chronic hepatitis B.

Authors:  Shogo Ohkoshi; Haruka Hirono; Kazuhiko Watanabe; Katsuhiko Hasegawa; Kenya Kamimura; Masahiko Yano
Journal:  World J Gastroenterol       Date:  2016-06-28       Impact factor: 5.742

2.  Cross-vendor validation of liver magnetic resonance elastography.

Authors:  Suraj D Serai; Meng Yin; Hui Wang; Richard L Ehman; Daniel J Podberesky
Journal:  Abdom Imaging       Date:  2015-04

3.  Bone marrow stromal cells control the growth of hepatic stellate cells in vitro.

Authors:  Lijun Shi; Guozhong Li; Jinghua Wang; Bo Sun; Liming Yang; Guangyou Wang; Dandan Wang; Lili Mu; Hui Chen; Lianhong Jin; Nikolaos Kostulas; Hulun Li
Journal:  Dig Dis Sci       Date:  2008-03-20       Impact factor: 3.199

4.  Pediatric liver MR elastography.

Authors:  Suraj D Serai; Alexander J Towbin; Daniel J Podberesky
Journal:  Dig Dis Sci       Date:  2012-05-09       Impact factor: 3.199

5.  Gluten-Free hepatomiracle in "celiac hepatitis": A case highlighting the rare occurrence of nutrition-induced near total reversal of advanced steatohepatitis and cirrhosis.

Authors:  Kavita Gaur; Puja Sakhuja; Amarender S Puri; Kaushik Majumdar
Journal:  Saudi J Gastroenterol       Date:  2016-11       Impact factor: 2.485

6.  Regression of fibrosis in pediatric liver diseases.

Authors:  Vikrant Sood; Bikrant Bihari Lal; Archana Rastogi; Rajeev Khanna; Dinesh Rawat; Seema Alam
Journal:  Indian J Gastroenterol       Date:  2018-05-09

Review 7.  Reversal of hepatic fibrosis: pathophysiological basis of antifibrotic therapies.

Authors:  Mona H Ismail; Massimo Pinzani
Journal:  Hepat Med       Date:  2011-07-04

8.  Cholic acid for primary bile acid synthesis defects: a life-saving therapy allowing a favorable outcome in adulthood.

Authors:  Emmanuel Gonzales; Lorenza Matarazzo; Stéphanie Franchi-Abella; Alain Dabadie; Joseph Cohen; Dalila Habes; Sophie Hillaire; Catherine Guettier; Anne-Marie Taburet; Anne Myara; Emmanuel Jacquemin
Journal:  Orphanet J Rare Dis       Date:  2018-10-29       Impact factor: 4.123

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.